High-risk Human Papillomavirus Testing for Cervical Cancer Screening

被引：2
|
作者：
Totten, Stephanie P. S. [1 ,2 ]
Romero, Joan Miguel [1 ,3 ]
机构：
[1] McGill Univ, Fac Med, Montreal, PQ, Canada
[2] Lady Davis Inst Med Res, Montreal, PQ, Canada
[3] Rosalind & Morris Goodman Canc Res Ctr, 1160 Pine Ave W,Room 611D, Montreal, PQ H3A 1A3, Canada
来源：
JAMA ONCOLOGY | 2021年 / 7卷 / 07期
关键词：
D O I：
10.1001/jamaoncol.2021.0735
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1066 / 1067
页数：9
相关论文
共 50 条
  • [41] Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening
    Luo, Hongxue
    Belinson, Jerome L.
    Du, Hui
    Liu, Zhihong
    Zhang, Lijie
    Wang, Chun
    Qu, Xinfeng
    Pretorius, Robert G.
    Wu, Ruifang
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2017, 21 (01) : 12 - 16
  • [42] High-risk Human Papillomavirus in a screening population
    Schledermann, D. E.
    Rasmussen, M.
    Mose, L.
    APMIS, 2011, 119 : 18 - 19
  • [43] High-Risk Human Papillomavirus Load and Biomarkers in Cervical Intraepithelial Neoplasia and Cervical Cancer
    Chang, M. S.
    Oh, S.
    Jeong, E-J
    Park, J. H.
    Kim, J. H.
    Park, I-A
    LABORATORY INVESTIGATION, 2013, 93 : 269A - 269A
  • [44] Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China A Multicenter, Open-Label, Randomized Clinical Trial
    Zhang, Junji
    Zhao, Yuqian
    Dai, Yi
    Dang, Le
    Ma, Li
    Yang, Chunxia
    Li, Yang
    Kong, Linghua
    Wei, Lihui
    Zhang, Shulan
    Liu, Jihong
    Xi, Minrong
    Chen, Long
    Duan, Xianzhi
    Xiao, Qing
    Abulizi, Guzhalinuer
    Zhang, Guonan
    Hong, Ying
    Gao, Xiaohong
    Zhou, Qi
    Xie, Xing
    Li, Li
    Niyazi, Mayinuer
    Zhang, Zhifen
    Tuo, Jiyu
    Ding, Yiling
    Si, Manfei
    Chen, Fei
    Song, Li
    Qiao, Youlin
    Lang, Jinghe
    JAMA ONCOLOGY, 2021, 7 (02) : 263 - 270
  • [45] High-risk human papillomavirus testing for cervical cancer screening in Uganda: Considering potential harms and benefits in a low-resource setting
    Sultanov, Marat
    Koot, Jaap A. R.
    de Bock, Geertruida H.
    Greuter, Marcel J. W.
    Beltman, Jogchum J.
    de Fouw, Marlieke
    de Zeeuw, Janine
    Kabukye, Johnblack
    Stekelenburg, Jelle
    van der Schans, Jurjen
    PLOS ONE, 2024, 19 (10):
  • [46] High-Risk Human Papillomavirus Load and Biomarkers in Cervical Intraepithelial Neoplasia and Cervical Cancer
    Chang, M. S.
    Oh, S.
    Jeong, E-J
    Park, J. H.
    Kim, J. H.
    Park, I-A
    MODERN PATHOLOGY, 2013, 26 : 269A - 269A
  • [47] The performance of human papillomavirus high-risk DNA testing in the screening and diagnostic settings
    Cardenas-Turanzas, Marylou
    Nogueras-Gonzalez, Graciela M.
    Scheurer, Michael E.
    Adler-Storthz, Karen
    Benedet, J. L.
    Beck, J. Robert
    Follen, Michele
    Cantor, Scott B.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (10) : 2865 - 2871
  • [48] Impact of High-Risk Human Papillomavirus Testing on Pap Test Screening Complexity
    Torous, Vanda
    Brancely, Dawn
    Carpio, Luis
    VanderLaan, Paul
    MODERN PATHOLOGY, 2017, 30 : 121A - 121A
  • [49] Impact of High-Risk Human Papillomavirus Testing on Pap Test Screening Complexity
    Torous, Vanda
    Brancely, Dawn
    Carpio, Luis
    VanderLaan, Paul
    LABORATORY INVESTIGATION, 2017, 97 : 121A - 121A
  • [50] High-risk human papillomavirus DNA testing and high-grade cervical intraepithelial lesions
    You, Ke
    Liang, Xueai
    Qin, Fengjin
    Guo, Yanli
    Geng, Li
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2007, 47 (02): : 141 - 144
12345